301239 普瑞眼科
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)3.401-2.941-4.63712.2921.364
总资产报酬率 ROA (%)1.519-1.331-2.1646.3100.685
投入资产回报率 ROIC (%)1.725-1.514-2.4807.1160.758

边际利润分析
销售毛利率 (%)41.09635.91236.98143.99941.673
营业利润率 (%)11.4891.1110.26514.2033.914
息税前利润/营业总收入 (%)13.8883.6022.20515.7076.185
净利润/营业总收入 (%)8.898-1.920-3.46610.2291.192

收益指标分析
经营活动净收益/利润总额(%)101.970408.698-17.02082.91180.927
价值变动净收益/利润总额(%)-1.127-81.24813.50121.61325.612
营业外收支净额/利润总额(%)-1.902-148.285127.308-6.563-14.035

偿债能力分析
流动比率 (X)1.1620.9900.9671.1652.040
速动比率 (X)0.9100.7570.8021.0191.855
资产负债率 (%)54.71554.63053.86851.85443.771
带息债务/全部投入资本 (%)20.27418.11117.56212.43910.562
股东权益/带息债务 (%)248.850281.742295.879441.914582.388
股东权益/负债合计 (%)81.39382.04584.84591.783128.462
利息保障倍数 (X)5.3131.1420.6946.6022.247

营运能力分析
应收账款周转天数 (天)10.44612.75814.81111.75111.729
存货周转天数 (天)39.92435.23731.97730.64735.349